Q2 2022 NantHealth Inc Earnings Call

have got financial measures in its financial results announcement.

Reconciliation of non-GAAP financial measures to the most directly comparable GAAP financial measures is also attached in the company's earnings press release issued earlier today.

In a moment, we discussed the business powered by power and discussed financial issues.

We will then open the call for questions.

That said, I will now turn the call of Geron-Luxon.

Good afternoon, everyone. Welcome to the MAMNHouse 2022, the second quarter of financial results conference call.

Charity briefing to our financial performance. We reported total revenue is $16.5 million, the third consecutive quarter of top line growth. The growth market for the quarter was 55%.

As we have been saying for several quarters, Center for our Growth Strategy is a commitment to investing in our products and services. As you are here in a moment, during the quarter we continue to launch new products, enhance existing ones, and with regard to our ability to connect our For Automated Disease Program, we continue to roll out new drugs and new drug regimens. We continue to roll out new drugs and new drug regimens.

Now let's discuss our software and services business, beginning with our MD business.

In the second quarter every connect froncology 1- the spring digital health- connected digital health- MERIT award and recognition of the product's credibility and relevance of content design.

We received approval for full delegated entity status in three additional states, Mississippi, Virginia, and Iowa. This designation allows customers need to be fully supported for delegated entity services and provides growth opportunities with new customers in those states.

We significantly grew the autoimmune offering, the coverage of more diseases, drugs and treatments. This expanded offering ensures a greater number of patients receive appropriate care while further growing their heart savings that Ebony for autoimmune disease provides to customers.

And we introduced new site of service functionality to increase cost saving opportunities for customers using Evity Connect for autoimmune diseases.

now using are seamlessly redirected to the appropriate site of service for each drug in the treatment plan.

Turning to pair engagement.

In May, we won the MedTech Breakthrough Healthcare Insurance Innovation Award, and the recognition of the platform's ability to break through digital health and technology markets.

In June , we won the Spring Digital Health, Connected Digital Health Marital War from the Healthy Information Resource Center, which honors the world's best health resources created for consumers and health professions. 2021 Preference to milk drives and health professionals.

We added a new line of business with a major healthcare payer in strategic partner, which along with two other lines of business is expected to go live in the second half of the current year. And we added new capabilities to enable that open authorizations, including the ability to collect situational patient information as part of a prior authorization submission, making it easier for health fans to meet state and regulatory requirements.

Turning to our network monitoring business, the Open NMS group. We released Open NMS Horizon 30, which introduced advancements to help organizations detect anomalies and changes in network traffic, ensuring that networks stay healthy and bandwidth related issues are properly identified. The Open NMS group is currently in bandwidth related issues is currently available in the Open NMS group. We are currently available in the Open NMS group. We are currently providing infrastructure Vehicles gör lavender, partner armor in the FCI, k1a2 expected sauceheadnave, and bone metal running, gmail closing B blank, gmail closing B blank, gmail closing B blank, gmail closing B blank, gmail closing Cl Acc för dans???ER GeINtorjournnerger S4K on YouTube, gmail closing Cl Acc har hCarrure.com, gmail closing Phoneisons Coyote alliance CI20 SpyJud?erEO installapp Sel??Jued.com, gmail swindtransl ?dm7irungre, S4koffer, 1x C1a2, shock steering P Doctors and D3, automated communicationC1i.com, tvenda3 des?akeles, Maryland Move a audio phone, Bye.

We released Grafana plugin, OpenNSL version 8.0. Grafana dashboards can now incorporate filtering by monitoring location, improve flow metrics, and support to display data more dynamically.

We released AI Component Out, Architecture for Learning-enabled Correlation, version 2.0. Users can now view correlated situations and their alarms directly in the topology map. Finally, we released the OpenNMS plugin API 1.0, which provides a development ecosystem that clearly identifies documents and provides ongoing compatibility guarantees for integration points.

To sum up, our products received three industry awards in the quarter in recognition of their innovation and value to customers. To sum up, our products received three industry awards value to customers.

Gravity is increased for the third consecutive quarter and gross margin of around 55% of revenue consistent over the last three years. We continue to launch new products and enhance versions of existing products. Also, we continue to roll out new drugs and new drug regimens for every connect product of mean diseases product and expect to launch the ID ID treatment soon. With that overview of our business, I'll turn the call over to Bob to discuss our financial results in more detail. Thank you.

Thank you, Ron. For a Q2 2022, total revenue was $16.5 million compared with $16.1 million in the prior year of second quarter.

The year on your increase was mainly due to growth and increased equity services from the previous year. Year to day, revenue from 2022 is up approximately 2% from the same period last year. You're currently working on a monthly increase on qualified wages for a anyway increase for more income monthly has led to a 12% and it becomes one of the average expenses you get end of employment rather fine. Bless you! Do you need any details? Say, five so agreed on resetime. here.

Gross profit for the quarter was 9.2 million, which is a slight increase. 5. vacations. 0. Please.

From 9.1 million the same quarter last year, rose profit percent was 55% down from 56% this quarter last year. This quarter last year. This quarter last year.

All operating expenses increased 15% to 20.9 million from 17.7 million in the prior year of second quarter. of Sedgapautor.

This is a function of the continued investments we are making in our product for foils and our platform and infrastructure technology build out.

For acute 2222, that loss from continuing operations was 12.5 million or 11 cents per share. This is compared with 15.5 million or 13 cents per share in the prior second quarter. For the first time, that loss from continuing operations was 12.5 million or 13 cents per share in the prior second quarter.

On the non-GAAP basis, net loss from continuing operations in Q2 2022 was $11.4 million, or $0.10 per share. This compared with $0.09 million, or $0.08 per share, for the second quarter of last year.

Finally, fashion and cash equivalence were approximately 5.7 million at June 30, 2022, which is compared with 16.1 million at March 31, 2022.

Usage of CAS was approximately $10.4 million, which was driven by interest payments, labor expenses, and other work and capital needs. With that, I will now turn the call back over to Robert.

Thanks Bob, operator that completes our prepared remarks. We'd now like to open and call the questions.

Thank you. If you would like to read a short question, please just a one followed by the four on your telephone. Please just a one followed by the four on your telephone.

You will hear a three-tone prompt technology request.

If you have any questions about the entry you would like to with a dry registration, please set the one followed by the three.

One moment, please, for the first question.

There are no questions at this time. I'll now turn the call back to you. Please continue with the presentation and or closing remarks.

Thanks operator and thank you everyone for joining us today. We look forward to sharing our power progress on the next planned conference call. Have a great night.

That does conclude the conference call for today. We thank you for participation and ask you to please disconnect your line.

Not.

Q2 2022 NantHealth Inc Earnings Call

Demo

NantHealth

Earnings

Q2 2022 NantHealth Inc Earnings Call

NH

Thursday, August 4th, 2022 at 8:30 PM

Transcript

No Transcript Available

No transcript data is available for this event yet. Transcripts typically become available shortly after an earnings call ends.

Want AI-powered analysis? Try AllMind AI →